Cargando…

IM-7 Identification of novel glioblastoma specific antigen using patient derived tumor cell for CAR-T cell therapy

Chimeric antigen receptor T (CAR-T) cell therapy is a newly developed antitumor immunotherapy presenting remarkable clinical response with leukemia, and is expected to be applied to other malignant solid tumors including glioblastoma (GBM). However, for development of CAR-T therapy against GBM, iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Tomoyoshi, Kijima, Noriyuki, Hasegawa, Kana, Kuroda, Hideki, Hirayama, Ryuichi, Okita, Yoshiko, Kagawa, Naoki, Kanemura, Yonehiro, Hosen, Naoki, Kishima, Haruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648191/ http://dx.doi.org/10.1093/noajnl/vdab159.029

Ejemplares similares

Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy
por: Nakagawa, Tomoyoshi, et al.
Publicado: (2022)

COT-16 Development of automatic lesion extraction application using artificial intelligence for the purpose of simplifying tumor volume measurement of meningioma
por: Hirayama, Ryuichi, et al.
Publicado: (2021)

TB-9 An attempt to establish a patient-derived brain tumor culture model by organoid culture method
por: Kuroda, Hideki, et al.
Publicado: (2021)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

COT-18 Prognosis and problems about secondary intracranial neoplasm in childhood cancer survivors: a single-institution retrospective cohort study
por: Kagawa, Naoki, et al.
Publicado: (2020)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

GCT-21. Long-term outcome and follow up of intracranial germ cell tumors: Reduced-dose radiotherapy and intensified chemotherapy improves clinical outcome and quality of life for long-term survivors
por: Kagawa, Naoki, et al.
Publicado: (2022)

Surgical resection of glioblastoma in basal ganglia and utility of exoscope: Technical case reports
por: Kijima, Noriyuki, et al.
Publicado: (2023)

How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas?
por: Yamada, Shuhei, et al.
Publicado: (2021)

MNG-08 VOLUMETRIC STUDIES IN ASYMPTOMATIC MENINGIOMAS: SLOWDOWN CASES AND GROWTH ARREST CASES
por: Hirayama, Ryuichi, et al.
Publicado: (2019)

NI-13 The effectiveness and limitation of survival prediction in primary glioblastoma using machine learning-based texture analysis
por: Umehara, Toru, et al.
Publicado: (2020)

NI-13 PREDICTION OF PROGNOSIS IN NEWLY DIAGNOSED GLIOBLASTOMA USING MACHINE LEARNING-BASED TEXTURE ANALYSIS OF PREOPERATIVE MRI
por: Umehara, Toru, et al.
Publicado: (2019)

QOL-44. ASSESSMENT OF NEUROCOGNITIVE FUNCTION AND MRI PARAMETERS IN LONG-TERM SURVIVORS WITH POSTERIOR FOSSA TUMORS: A COMPARISON BETWEEN MEDULLOBLASTOMAS TREATED BY REDUCED-DOSE CRANIOSPINAL IRRADIATION AND OTHER TUMORS
por: Kagawa, Naoki, et al.
Publicado: (2020)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

GCT-69. VOLUMETRIC CHANGE BEFORE CHEMORADIOTHERAPY AND INFLUENCE OF DIAGNOSTIC RADIATION EXPOSURE IN INTRACRANIAL GERMINOMAS
por: Kagawa, Naoki, et al.
Publicado: (2020)

Surgical Treatment of Brain Metastasis of Extramammary Paget’s Disease: A Case Report
por: Miura, Shimpei, et al.
Publicado: (2020)

SS-2 Current status and future perspective of radiomics in glioma imaging
por: Kinoshita, Manabu, et al.
Publicado: (2020)

STMO-10 SURGICAL RESECTION FOR PRIMARY MOTOR CORTEX GLIOMA, TWO CASE REPORTS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS
por: Kagawa, Naoki, et al.
Publicado: (2019)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Successful neurosurgical separation of conjoined spinal cords in pygopagus twins: illustrative cases
por: Yokota, Chisato, et al.
Publicado: (2021)

TB-8 Genetic and molecular properties of long-term proliferating tumorsphere -forming glioma derived cells
por: Kijima, Noriyuki, et al.
Publicado: (2021)

Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report
por: Yamada, Shuhei, et al.
Publicado: (2022)

Endovascular Treatment for Middle Cerebral Artery Aneurysms: Single-Center Experience and Review of Literatures
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

NI-12 The ratio of T1-Weighted to T2-Weighted Signal Intensity and IDH mutation in glioma
por: Sanada, Takahiro, et al.
Publicado: (2021)

NI-2 Use of neurite orientation dispersion and density imaging(NODDI)for early distinction between infiltrating tumor and vasogenic edema in non-enhancing lesions with glioblastoma patients
por: Okita, Yoshiko, et al.
Publicado: (2021)

Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
por: Yokota, Chisato, et al.
Publicado: (2021)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map
por: Yamamoto, Shota, et al.
Publicado: (2022)

IM-8 Significance of IL-1 pathways in Glioblastoma
por: Kai, Keitaro, et al.
Publicado: (2021)

Reverse Engineering Glioma Radiomics to Conventional Neuroimaging
por: KINOSHITA, Manabu, et al.
Publicado: (2021)

Chimeric antigen receptor T cell therapy for multiple myeloma
por: Hasegawa, Kana, et al.
Publicado: (2019)

Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via (11)C-methionine positron emission tomography
por: Ozaki, Tomohiko, et al.
Publicado: (2019)

NI-07 VALIDATION OF MACHINE LEARNING BASED HIGH GRADE GLIOMA MR SEGMENTATION VIA METHIONINE PET
por: Kinoshita, Manabu, et al.
Publicado: (2019)

ACT-07 Clinical Trials of 11C-Methionine PET for brain tumors
por: Yamaguchi, Shigeru, et al.
Publicado: (2020)

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts
por: Umehara, Toru, et al.
Publicado: (2019)

T(2)-FLAIR Mismatch Sign Is Caused by Long T(1) and T(2) of IDH-mutant, 1p19q Non-codeleted Astrocytoma
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion
por: Achiha, Takamune, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tce929ue2pndkeb03pfeh5jmb2